Respiri Limited (AU:RSH) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Respiri Limited is making strides in the US healthcare market with its innovative eHealth solutions, inviting investors to a webinar to discuss recent achievements and future goals. Known for its cutting-edge technology like the FDA-approved wheezo® device, Respiri is focused on transforming chronic disease management through remote patient monitoring. As the company aims for a cash flow positive outcome by the end of 2024, its strategic partnerships and advanced programs are set to reduce healthcare costs and improve patient care.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
